Life Science and Health Care Publications

Healthcare and Life Sciences Predictions 2020: Taxing times ahead

Tax is a hot topic right now for big business and will have major repercussions for the healthcare and life sciences industry. This paper looks at Deloitte’s original flagship report, ‘Healthcare and life sciences predictions 2020: A bold future’, published in November 2014, and explores what these predictions will mean for tax. It also forms its own tax prediction to illustrate what the future of Tax could look like for the industry in 2020.

Click to continue.

Devices and diseases: How the IoT is transforming medtech

The importance of data in delivering efficient, effective health care has long been obvious—and has never been greater. The increased focus on value-based care is shifting financial incentives to a model in which providers are compensated based on how their patients fare, rather than by the number of tests, visits, or procedures performed. This means that providers, patients, and everyone in between are more eager than ever to measure patient outcomes in order to determine what works and who gets paid.

Click to continue

Measuring the return from pharmaceutical innovation 2015

Macroeconomic pressures have hit the R&D returns of life sciences firms, according to new Deloitte research. The sixth annual pharmaceutical innovation study looks at the challenges the industry faces in generating returns from its R&D investments, while highlighting lessons that can be learned.

Click to continue

No appointment necessary

As health systems continue to face shrinking margins, tightening budgets, and evolving payment models, analytics are being touted as the missing key to unlock new sources of value.

Click to continue

Health system analytics

The missing key to unlock value-based care

As health systems continue to face shrinking margins, tightening budgets, and evolving payment models, analytics are being touted as the missing key to unlock new sources of value.

Click to continue.

Health & Wellness Progress Report 2015

Developing solutions for positive change

The effort to address health and wellness on a global scale becomes more critical every day. Industry leaders work with each other and with external stakeholders to meet the challenges. This report presents an overview of the topic, key findings and industry activities, and recommended next steps.

Click to continue

In pursuit of innovation

CEO checklist

Built around four key components – approach, organization, resources & competencies, and metrics & incentives – “A CEO checklist” can help health care leaders determine if their organization’s approach to innovation measures up to that of demonstrably successful innovators.

Click to continue

Rising consumerism

Winning the hearts and minds of health care consumers

The intersection between rising consumerism and a growing retail orientation in the health care sector presents challenges for existing players. This report explores three shifts that health industry players should respond to, and that can set the scene for greater consumer involvement.

Click to continue

2015 Global health care sector outlook

Across the globe, governments, health care delivery systems, insurers, and consumers are engaged in a persistent tug-of-war between competing priorities: meeting the increasing demand for health care services and reducing the rising cost of those services.

Click to continue

2015 Global life sciences sector outlook

Aging populations, chronic/lifestyle diseases, emerging-market expansion, and treatment and technology advances are expected to spur life sciences sector growth in 2015. However, efforts by governments, health care providers, and health plans to reduce costs, improve outcomes, and demonstrate value is dramatically altering the health care demand and delivery landscape. It is becoming increasingly evident that the global life sciences sector is operating in an era of significant transformation.

Click to continue

Healthcare and Life Sciences Predictions 2020

The Deloitte Center for Health Solutions has revealed a bold vision for the Healthcare and Life Sciences sector in 2020. The report, which launched at the 2014 FT Global Pharmaceutical and Biotechnology Conference, sets out ten provocative predictions for 2020.

Click to continue

Measuring the return from pharmaceutical innovation

Turning a corner?

The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.

Click to continue

Strategic alliances in Life Sciences

Life sciences companies have adopted a multi-track approach to cope with the current and anticipated drop in sales revenue. Next to classic mergers and acquisitions (M&A) Strategic Alliances have proven to be a viable alternative in coping with these challenges.

Click to continue

The tail wagging the dog

How retail is changing consumer expectations of the health care patient-provider relationship

Outpatient satisfaction levels are trending downward. Consumers are starting to exert their power by making more demands on the health care provider-patient relationship and expecting to be treated in much the same way they are accustomed to being treated in their daily interactions with retailers.

Click to continue

2014 Global life sciences sector outlook

Resilience and reinvention in a changing marketplace

Despite increased regulation, pricing pressures and the effects of health care reform in many countries, the global life sciences sector is exhibiting resilience and reinvention as it employs new research and development (R&D) and business models to cost-effectively deliver innovation, value, and improved patient outcomes.

Click to continue